Conference Coverage

Measures of PTH predict postthyroidectomy hypocalcemia


 

FROM AAO-HNS ANNUAL MEETING

More proof of PTH’s predictive power

“The utility of postoperative PTH for predicting symptomatic hypocalcemia is beneficial for guiding postoperative management of patients following total thyroidectomy,” said Larissa Sweeny, MD, of the University of Miami, who served as a moderator for the session in which the study was presented.

“Proper identification of patients that require supplemental medications following surgery reduces administration of medications to patients that do not require supplemental medications,” Dr. Sweeny said in an interview.

In addition, better identification not only ensures that the patients who do require supplemental medications receive them but also reduces postoperative complications and readmissions, she said.

For clinical practice, the current study “reinforces the utility of postoperative PTH lab values for guiding medication administration following total thyroidectomy,” said Dr. Sweeny. “I have been using postoperative PTH lab values following total thyroidectomy to guide my postoperative management of these patients for over 6 years.”

However, looking ahead to additional research, “Correlation with dosage of supplemental calcium and duration to return of normal PTH would be helpful information,” Dr. Sweeny said.

The study received no outside funding. The researchers and Dr. Sweeny report no relevant financial relationships.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

New EU guidelines: Individualize care for thyroid cancer in kids
MDedge Hematology and Oncology
USPSTF holds firm on postmenopausal hormone recommendations
MDedge Hematology and Oncology
Lifestyle choices could curb genetic risk for thyroid cancer
MDedge Hematology and Oncology
Commenting on weight’s not rude. It’s dangerous.
MDedge Hematology and Oncology
Taking a break from TKIs unlikely to shorten survival
MDedge Hematology and Oncology
TikTok’s fave weight loss drugs: Link to thyroid cancer?
MDedge Hematology and Oncology
EPA seeks to limit ‘forever’ chemicals in U.S. drinking water
MDedge Hematology and Oncology
Increased cancer in military pilots and ground crew: Pentagon
MDedge Hematology and Oncology
Radiofrequency ablation successful in small thyroid cancers
MDedge Hematology and Oncology
Triple therapy boosts anaplastic thyroid cancer survival
MDedge Hematology and Oncology